Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1968 1
1970 1
1974 2
1980 2
1981 2
1982 2
1983 2
1984 1
1986 2
1987 2
1988 5
1989 1
1990 4
1991 3
1992 12
1993 9
1994 14
1995 6
1996 8
1997 4
1998 10
1999 4
2000 8
2001 9
2002 9
2003 6
2004 10
2005 7
2006 9
2007 5
2008 12
2009 3
2010 6
2011 7
2012 7
2013 7
2014 11
2015 9
2016 5
2017 6
2018 4
2019 8
2020 11
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

245 results
Results by year
Filters applied: . Clear all
Page 1
Characterization of the Inflammatory Response to Severe COVID-19 Illness.
McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, Ní Choileáin O, Clarke J, O'Connor E, Hogan G, Ryan D, Sulaiman I, Gunaratnam C, Branagan P, O'Brien ME, Morgan RK, Costello RW, Hurley K, Walsh S, de Barra E, McNally C, McConkey S, Boland F, Galvin S, Kiernan F, O'Rourke J, Dwyer R, Power M, Geoghegan P, Larkin C, O'Leary RA, Freeman J, Gaffney A, Marsh B, Curley GF, McElvaney NG. McElvaney OJ, et al. Among authors: o brien me. Am J Respir Crit Care Med. 2020 Sep 15;202(6):812-821. doi: 10.1164/rccm.202005-1583OC. Am J Respir Crit Care Med. 2020. PMID: 32584597 Free PMC article.
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
Kelly K, Altorki NK, Eberhardt WE, O'Brien ME, Spigel DR, Crinò L, Tsai CM, Kim JH, Cho EK, Hoffman PC, Orlov SV, Serwatowski P, Wang J, Foley MA, Horan JD, Shepherd FA. Kelly K, et al. Among authors: o brien me. J Clin Oncol. 2015 Dec 1;33(34):4007-14. doi: 10.1200/JCO.2015.61.8918. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324372 Clinical Trial.
An integrated multidisciplinary model of COVID-19 recovery care.
O'Brien H, Tracey MJ, Ottewill C, O'Brien ME, Morgan RK, Costello RW, Gunaratnam C, Ryan D, McElvaney NG, McConkey SJ, McNally C, Curley GF, MacHale S, Gillan D, Pender N, Barry H, de Barra E, Kiernan FM, Sulaiman I, Hurley K. O'Brien H, et al. Among authors: o brien me. Ir J Med Sci. 2021 May;190(2):461-468. doi: 10.1007/s11845-020-02354-9. Epub 2020 Sep 7. Ir J Med Sci. 2021. PMID: 32894436 Free PMC article.
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback DG, Tomczak P, Ackland SP, Orlandi F, Mellars L, Alland L, Tendler C; CAELYX Breast Cancer Study Group. O'Brien ME, et al. Ann Oncol. 2004 Mar;15(3):440-9. doi: 10.1093/annonc/mdh097. Ann Oncol. 2004. PMID: 14998846 Free article. Clinical Trial.
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer.
von Pawel J, Jotte R, Spigel DR, O'Brien ME, Socinski MA, Mezger J, Steins M, Bosquée L, Bubis J, Nackaerts K, Trigo JM, Clingan P, Schütte W, Lorigan P, Reck M, Domine M, Shepherd FA, Li S, Renschler MF. von Pawel J, et al. Among authors: o brien me. J Clin Oncol. 2014 Dec 10;32(35):4012-9. doi: 10.1200/JCO.2013.54.5392. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385727 Clinical Trial.
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.
Peters S, Danson S, Hasan B, Dafni U, Reinmuth N, Majem M, Tournoy KG, Mark MT, Pless M, Cobo M, Rodriguez-Abreu D, Falchero L, Moran T, Ortega Granados AL, Monnet I, Mohorcic K, Sureda BM, Betticher D, Demedts I, Macias JA, Cuffe S, Luciani A, Sanchez JG, Curioni-Fontecedro A, Gautschi O, Price G, Coate L, von Moos R, Zielinski C, Provencio M, Menis J, Ruepp B, Pochesci A, Roschitzki-Voser H, Besse B, Rabaglio M, O'Brien MER, Stahel RA. Peters S, et al. Among authors: o brien mer. J Thorac Oncol. 2020 Oct;15(10):1647-1656. doi: 10.1016/j.jtho.2020.06.011. Epub 2020 Jun 18. J Thorac Oncol. 2020. PMID: 32565388 Clinical Trial.
BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications.
Weathington N, O'Brien ME, Radder J, Whisenant TC, Bleecker ER, Busse WW, Erzurum SC, Gaston B, Hastie AT, Jarjour NN, Meyers DA, Milosevic J, Moore WC, Tedrow JR, Trudeau JB, Wong HP, Wu W, Kaminski N, Wenzel SE, Modena BD. Weathington N, et al. Among authors: o brien me. Am J Respir Crit Care Med. 2019 Oct 1;200(7):837-856. doi: 10.1164/rccm.201811-2221OC. Am J Respir Crit Care Med. 2019. PMID: 31161938 Free PMC article.
Risk of Serotonin Syndrome with Isoniazid.
O'Brien ME, Gandhi RG, Kotton CN, Adamsick ML. O'Brien ME, et al. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01455-20. doi: 10.1128/AAC.01455-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33077663 No abstract available.
The Royal College of surgeons multidisciplinary guidelines on elective tracheostomy insertion in COVID-19 ventilated patients.
Jones H, Gendre A, Walshe P, Walsh M, Glynn F, Lacy P, Gaffney R, McConn Walsh R, Mamdouh S, O'Rourke J, Morgan R, O'Brien ME, Shine N, Curley GF, O'Neill JP. Jones H, et al. Among authors: o brien me. Surgeon. 2020 Dec 29:S1479-666X(20)30188-8. doi: 10.1016/j.surge.2020.12.002. Online ahead of print. Surgeon. 2020. PMID: 33423925 Free PMC article. Review.
245 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page